Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Two US Navy destroyers sail through Taiwan Strait

2018-07-10 janes
Two US Navy (USN) destroyers have sailed through the 180 km (110 m)-wide Taiwan Strait for the first time in about a year.
MND

0
REGIONAL FOCUS Asia-Pacific [ES18D3]

2018-06-13 janes
North Korea’s nuclear weapons programme and potential thaw in relations with the US, a border stand-off between India and China, fighting in the southern Philippines, large naval procurement programmes in Southeast Asia, and a new US strategy for Afghanistan have made for a busy year in the Asia- Pacific region.
MND

0
Taiwan welcomes potential US policy shift in military sales

2018-06-07 janes
Taiwan has welcomed a potential shift in policy by the United States government to facilitate military sales to the country on a case-by-case basis as opposed to the current approach of ‘bundling’ several defence deals together.
MND

0
PLA airborne troops conduct first exercise with Y-20 transport aircraft

2018-05-10 janes
China’s People’s Liberation Army Air Force (PLAAF) has conducted its first airdrop and air delivery training exercise using the Xian Aircraft Corporation Y-20 Kunpeng strategic transport aircraft, the Ministry of National Defense (MND) in Beijing announced on 8 May.
MND

0
South Korea and Philippines commit to industrial engagement

2018-05-02 janes
South Korea and the Philippines have agreed to expand military industrial collaboration in support of existing and future defence trade programmes.
MND

0
PLAN assembles its largest ever formation of ships

2018-04-16 janes
China’s People’s Liberation Army Navy (PLAN) paraded 48 naval vessels, 76 aircraft, and 10,000 personnel in a fleet review before President Xi Jinping in the South China Sea on 12 April.
MND

0
US approves marketing licence in support of Taiwan’s submarine programme

2018-04-09 janes
Taiwan’s Ministry of National Defense (MND) has said the US government has awarded a marketing licence in support of its efforts to develop and construct diesel-electric submarines.
MND

3
Poland signs Wisla offset agreement

2018-03-26 janes
Poland, Lockheed Martin, and Raytheon have signed offset agreements for the Wisła air defence programme worth nearly PLN950 million (USD277 million), the Polish Ministry of National Defence (MND) has announced.
LMT MND

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

6h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

7h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:MND / MND on message board site Silicon Investor.

MNDO : Will it go from here? Command Systems, Inc. (CMND)
New Shaman (SHMND) Discussion Group